Sino Biopharmaceutical Ltd
HKEX:1177

Watchlist Manager
Sino Biopharmaceutical Ltd Logo
Sino Biopharmaceutical Ltd
HKEX:1177
Watchlist
Price: 3.3 HKD 0.3% Market Closed
Market Cap: 60.5B HKD
Have any thoughts about
Sino Biopharmaceutical Ltd?
Write Note

Sino Biopharmaceutical Ltd
Total Equity

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Sino Biopharmaceutical Ltd
Total Equity Peer Comparison

Comparables:
G
512
U
3933
C
570
C
3320
H
13

Competitive Total Equity Analysis
Latest Figures & CAGR of Competitors

Company Total Equity CAGR 3Y CAGR 5Y CAGR 10Y
Sino Biopharmaceutical Ltd
HKEX:1177
Total Equity
ÂĄ32.8B
CAGR 3-Years
10%
CAGR 5-Years
2%
CAGR 10-Years
22%
G
Grand Pharmaceutical Group Ltd
HKEX:512
Total Equity
HK$15.7B
CAGR 3-Years
9%
CAGR 5-Years
15%
CAGR 10-Years
33%
U
United Laboratories International Holdings Ltd
HKEX:3933
Total Equity
ÂĄ13.5B
CAGR 3-Years
14%
CAGR 5-Years
16%
CAGR 10-Years
9%
C
China Traditional Chinese Medicine Holdings Co Ltd
HKEX:570
Total Equity
ÂĄ21.4B
CAGR 3-Years
4%
CAGR 5-Years
6%
CAGR 10-Years
22%
C
China Resources Pharmaceutical Group Ltd
HKEX:3320
Total Equity
HK$48.4B
CAGR 3-Years
0%
CAGR 5-Years
3%
CAGR 10-Years
N/A
H
HUTCHMED (China) Ltd
HKEX:13
Total Equity
$740.1m
CAGR 3-Years
-9%
CAGR 5-Years
16%
CAGR 10-Years
23%

See Also

What is Sino Biopharmaceutical Ltd's Total Equity?
Total Equity
32.8B CNY

Based on the financial report for Jun 30, 2024, Sino Biopharmaceutical Ltd's Total Equity amounts to 32.8B CNY.

What is Sino Biopharmaceutical Ltd's Total Equity growth rate?
Total Equity CAGR 10Y
22%

Over the last year, the Total Equity growth was 10%. The average annual Total Equity growth rates for Sino Biopharmaceutical Ltd have been 10% over the past three years , 2% over the past five years , and 22% over the past ten years .

Back to Top